Clinical Trial

Perioperative Hyperoxia vs Normoxia Biomarker Trial

Completed
View on ClinicalTrials.gov →
Summary
This single-center randomized interventional study evaluated the biological effects of two perioperative oxygen strategies in adults undergoing elective laparoscopic lower abdominal surgery under standardized general anesthesia. Participants were assigned to receive either normoxia (FiO2 0.35) or hyperoxia (FiO2 0.80) after intubation and throughout the intraoperative period. The study assessed perioperative changes in circulating biomarkers related to pulmonary epithelial stress, endothelial glycocalyx injury, oxidative stress, and inflammation, together with blood gas and hemodynamic parameters. The study was completed before registration and is being registered retrospectively.
Trial Details
NCT Number NCT07525661
Lead Sponsor Istanbul University
Conditions Hyperoxia, Perioperative Care, Oxidative Stress, Endothelial Glycocalyx Injury
Enrollment 76 participants
Start Date 2017-07-01
Primary Completion 2019-01-01 (estimated)
Study Completion 2019-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-13